# Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia

> **NCT02373579** · PHASE2 · COMPLETED · sponsor: **Nancy Samir Elbarbary** · enrollment: 70 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Omega-3 Fatty Acids
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02373579
- **Lead sponsor:** Nancy Samir Elbarbary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02373579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02373579, "Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02373579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*